Government news, all in one place
Government news, all in one place
The Medicines and Healthcare products Regulatory Agency (MHRA) is a UK government agency responsible for ensuring that medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy.
Based on publicly published press releases (last 12 months)
811 articles
Showing 1-30
Thursday, 12 March 2026
Expanding medicine reclassification could improve access to treatments, empower self-care, and reduce pressure on NHS services....
Thursday, 12 March 2026
As with any medicine, the MHRA will keep the safety and effectiveness of deuruxolitinib under close review....
Tuesday, 10 March 2026
New analysis shows Clinical Practice Research Datalink has supported groundbreaking medical research across 29 countries with close to 3,800 published...
Friday, 06 March 2026
The MHRA?has advised pharmacy and healthcare professionals to return all remaining stock to their suppliers...
Tuesday, 03 March 2026
A man who unlawfully supplied Class B and Class C controlled drugs and a range of unauthorised medicines has been sentenced at Stoke-on-Trent Crown Co...
Friday, 27 February 2026
As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants....
Wednesday, 25 February 2026
The MHRA invited the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK....
Wednesday, 25 February 2026
Officers from the MHRA's Criminal Enforcement Unit (CEU) have raided two separate premises as part of an ongoing investigation into an organised crimi...
Tuesday, 24 February 2026
Fake medicines are illegally produced products that may contain incorrect ingredients, no active ingredients, or harmful substances. ...
Tuesday, 24 February 2026
As with any medicine, the MHRA will keep the safety and effectiveness of imlunestrant tosylate under close review....
Tuesday, 24 February 2026
By Richard Stubbs...
Monday, 23 February 2026
As with any medicine, the MHRA will keep the safety and effectiveness of brensocatib under close review....
Friday, 20 February 2026
With all complex clinical trials, MHRA’s top priority is the safety and wellbeing of the trial participants ...
Thursday, 19 February 2026
Zanidatamab is used when the cancer cannot be removed by surgery and has spread to nearby tissues or other parts of the body. ...
Thursday, 19 February 2026
Patients benefit from earlier access to technologies that could improve or save lives, as the MHRA approved 17 per cent more clinical investigations i...
Monday, 16 February 2026
MHRA launches a consultation on indefinite recognition of CE-marked medical devices ...
Friday, 13 February 2026
People are urged to avoid risky online buys and protect their health, as the MHRA seizes over 4.4 million doses of unlicensed erectile dysfunction med...
Wednesday, 11 February 2026
The vaccine should not be used in people aged 60 or over, and in individuals of any age who have high blood pressure, heart disease, diabetes, or chro...
Thursday, 05 February 2026
MHRA updates product information regarding the very rare risk of non-arteritic anterior ischemic optic neuropathy (NAION) in patients taking semagluti...
Monday, 02 February 2026
By Julia Vitarello ...
Thursday, 29 January 2026
Updated product information for healthcare professionals and patients regarding the small risk of severe acute pancreatitis in patients taking GLP-1s...
Thursday, 29 January 2026
Batches of quetiapine oral suspension from Eaststone Limited are being recalled due to the active content being twice the amount it should be. Patient...
Wednesday, 28 January 2026
New online resources will help the public, parents, carers and health, social care and education professionals understand what safe, effective digital...
Monday, 26 January 2026
The Access Consortium?— comprising regulatory authorities from the UK, Australia, Canada, Singapore and Switzerland?— works together to streamline reg...
Monday, 26 January 2026
Nearly 20 million doses of potentially dangerous medicines prevented from reaching the public ...
Thursday, 22 January 2026
The updated safety measures will strengthen the MHRA’s ability to monitor safe prescribing while supporting patient access to treatment across all age...
Monday, 19 January 2026
Study confirms vaccine being used in global efforts to achieve and sustain polio eradication is successfully interrupting polio outbreaks whilst minim...
Saturday, 17 January 2026
Paracetamol should be taken as directed in the patient information leaflet....
Friday, 16 January 2026
The Medicines and Healthcare products Regulatory Agency (MHRA) approved a maximum dose of up to 7.2mg per week of semaglutide (Wegovy) on 6 January 20...
Tuesday, 13 January 2026
The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more quickly and boosting...
UK Health Security Agency Cases of invasive meningococcal disease notified in Kent
Government Property Agency Government Property Agency appoints new Chief Investment Officer
Department for Work and Pensions Welfare state to working state
HM Treasury Chancellor Rachel Reeves meeting with Tánaiste Simon Harris
Ministry of Defence Army announces three senior leadership appointments